Maria A. Lopez-Olivo

Maria A. Lopez-Olivo is a Professor at The University of Texas MD Anderson Cancer Center. Her research focuses on clinical rheumatology, cancer care, and health policy, with specific interests in shared decision-making, tobacco cessation interventions, and risk-based cancer screening. Her recent work includes developing a decision quality instrument for lung cancer screening (DQI-LCS), evaluating anti-nerve growth factor monoclonal antibodies for chronic musculoskeletal pain, and conducting systematic reviews on particle therapy economics and personalized cancer screening acceptability. She has published in The Lancet Public Health and Drugs, and leads international collaborations on evidence synthesis, including the application of artificial intelligence to support systematic review methodologies.